Trial Profile

Phase III Multicentric IIL Study, Three Randomized Arms (R−CVP vs R−CHOP vs R−FM), for Treatment of Patients With Stage II−IV Follicular Lymphoma. [Studio I.I.L. di fase III, multicentrico, randomizzato a tre bracci (R-CVP vs R-CHOP vs R-FM), per il trattamento di prima linea di pazienti con Linfoma Follicolare in stadio II-IV.]

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cyclophosphamide; Doxorubicin; Fludarabine; Mitoxantrone; Prednisone; Rituximab; Vincristine
Indications Follicular lymphoma
Focus Adverse reactions; Therapeutic Use

25 Mar 2013 Final results published in the Journal of Clinical Oncology.
05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
15 Feb 2011 Biomarkers information updated

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com